Tarsus Pharmaceuticals Inc (TARS)
Revenue
$606.33M
TTM · Period ending: · USD
TARS Revenue
Latest reported$606.33Mperiod ending
Latest reported$606.33Mperiod ending
TARS TTM Revenue ($0.00 → $606.33M)
TTM revenue
High-resolution chart · PNG
TARS revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Revenue (USD) |
|---|---|
| 606,331,000 | |
| 535,079,000 | |
| 451,360,000 | |
| 366,100,000 | |
| 295,521,000 | |
| 233,674,000 | |
| 182,953,000 | |
| 129,621,000 | |
| 83,374,000 | |
| 42,561,000 | |
| 17,447,000 | |
| 14,371,000 | |
| 12,500,000 | |
| 27,777,000 | |
| 25,816,000 | |
| 16,154,000 | |
| 17,394,000 | |
| 24,134,000 | |
| 57,027,000 | |
| 56,689,000 | |
| 55,449,000 | |
| 33,432,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |